PharVision Advisers’s Shake Shack SHAK Stock Holding History

PharVision Advisers’s Portfolio SHAK Stock Details SHAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,993	Closed	-$243K	–	558
2025 Q4	$243K	Sell	2,993 -1,937	-39%	-$171K	0.12%	413
2025 Q3	$461K	Buy	+4,930	New	+$566K	0.26%	34

Other funds holding SHAK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ACM

Anomaly Capital Management New York $2.62B AUM 23.26% 1-Year Est. Return

PharVision Advisers's SHAK Position: Q1 2026 in Review

PharVision Advisers sold out of Shake Shack (SHAK) in Q1 2026, closing a stake of 2,993 shares — an estimated $243K sold.

PharVision Advisers first reported a position in SHAK in Q3 2025 and held it in 2 quarters. The position peaked at $461K in Q3 2025. 371 funds tracked by Wall St. Rank hold SHAK as of Q1 2026.

PharVision Advisers reported no remaining Shake Shack position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 2,993 Shake Shack shares in Q1 2026, an estimated $243K.
PharVision Advisers first reported a position in Shake Shack in Q3 2025 and held it in 2 quarters.
PharVision Advisers's Shake Shack position peaked at $461K in Q3 2025.
371 funds tracked by Wall St. Rank held Shake Shack as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.